Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
11 05 2020
Historique:
received: 18 11 2019
revised: 27 01 2020
accepted: 04 02 2020
pubmed: 21 3 2020
medline: 12 11 2020
entrez: 21 3 2020
Statut: ppublish

Résumé

The aim of this study was to evaluate the impact of initial deployment orientation of SAPIEN 3, Evolut, and ACURATE-neo transcatheter heart valves on their final orientation and neocommissural overlap with coronary arteries. Coronary artery access and redo transcatheter aortic valve replacement (TAVR) following initial TAVR may be influenced by transcatheter heart valve orientation. In this study the impact of transcatheter heart valve deployment orientation on commissural alignment was evaluated. Pre-TAVR computed tomography and procedural fluoroscopy were analyzed in 828 patients who underwent TAVR (483 SAPIEN 3, 245 Evolut, and 100 ACURATE-neo valves) from March 2016 to September 2019 at 5 centers. Coplanar fluoroscopic views were coregistered to pre-TAVR computed tomography to determine commissural alignment. Severe overlap between neocommissural posts and coronary arteries was defined as 0° to 20° apart. The SAPIEN 3 had 1 commissural post crimped at 3, 6, 9, and 12 o'clock. The Evolut "Hat" marker and ACURATE-neo commissural post at deployment were classified as center back (CB), inner curve (IC), outer curve (OC), or center front (CF) and matched with final orientation. Initial SAPIEN 3 crimped orientation had no impact on commissural alignment. Evolut "Hat" at OC or CF at initial deployment had less severe overlap than IC or CB (p < 0.001) against the left main (15.7% vs. 66.0%) and right coronary (7.1% vs. 51.1%) arteries. Tracking Evolut "Hat" at OC of the descending aorta (n = 107) improved OC at deployment from 70.2% to 91.6% (p = 0.002) and reduced coronary artery overlap by 36% to 60% (p < 0.05). ACURATE-neo commissural post at CB or IC during deployment had less coronary artery overlap compared to CF or OC (p < 0.001), with intentional alignment successful in 5 of 7 cases. This is the first systematic evaluation of commissural alignment in TAVR. More than 30% to 50% of cases had overlap with 1 or both coronary arteries. Initial SAPIEN 3 orientation had no impact on alignment, but specific initial orientations of Evolut and ACURATE improved alignment. Optimizing valve alignment to avoid coronary artery overlap will be important in coronary artery access and redo TAVR.

Sections du résumé

OBJECTIVES
The aim of this study was to evaluate the impact of initial deployment orientation of SAPIEN 3, Evolut, and ACURATE-neo transcatheter heart valves on their final orientation and neocommissural overlap with coronary arteries.
BACKGROUND
Coronary artery access and redo transcatheter aortic valve replacement (TAVR) following initial TAVR may be influenced by transcatheter heart valve orientation. In this study the impact of transcatheter heart valve deployment orientation on commissural alignment was evaluated.
METHODS
Pre-TAVR computed tomography and procedural fluoroscopy were analyzed in 828 patients who underwent TAVR (483 SAPIEN 3, 245 Evolut, and 100 ACURATE-neo valves) from March 2016 to September 2019 at 5 centers. Coplanar fluoroscopic views were coregistered to pre-TAVR computed tomography to determine commissural alignment. Severe overlap between neocommissural posts and coronary arteries was defined as 0° to 20° apart. The SAPIEN 3 had 1 commissural post crimped at 3, 6, 9, and 12 o'clock. The Evolut "Hat" marker and ACURATE-neo commissural post at deployment were classified as center back (CB), inner curve (IC), outer curve (OC), or center front (CF) and matched with final orientation.
RESULTS
Initial SAPIEN 3 crimped orientation had no impact on commissural alignment. Evolut "Hat" at OC or CF at initial deployment had less severe overlap than IC or CB (p < 0.001) against the left main (15.7% vs. 66.0%) and right coronary (7.1% vs. 51.1%) arteries. Tracking Evolut "Hat" at OC of the descending aorta (n = 107) improved OC at deployment from 70.2% to 91.6% (p = 0.002) and reduced coronary artery overlap by 36% to 60% (p < 0.05). ACURATE-neo commissural post at CB or IC during deployment had less coronary artery overlap compared to CF or OC (p < 0.001), with intentional alignment successful in 5 of 7 cases.
CONCLUSIONS
This is the first systematic evaluation of commissural alignment in TAVR. More than 30% to 50% of cases had overlap with 1 or both coronary arteries. Initial SAPIEN 3 orientation had no impact on alignment, but specific initial orientations of Evolut and ACURATE improved alignment. Optimizing valve alignment to avoid coronary artery overlap will be important in coronary artery access and redo TAVR.

Identifiants

pubmed: 32192985
pii: S1936-8798(20)30489-1
doi: 10.1016/j.jcin.2020.02.005
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030-1042

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Gilbert H L Tang (GHL)

Department of Cardiovascular Surgery, Mount Sinai Medical Center, New York, New York. Electronic address: gilbert.tang@mountsinai.org.

Syed Zaid (S)

Division of Cardiology, Westchester Medical Center, Valhalla, New York.

Andreas Fuchs (A)

The Heart Center, Rigshospitalet, Copenhagen, Denmark.

Tsuyoshi Yamabe (T)

Division of Cardiac Surgery, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York.

Farhang Yazdchi (F)

Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Eisha Gupta (E)

Division of Cardiology, Mount Sinai Medical Center, New York, New York.

Hasan Ahmad (H)

Division of Cardiology, Westchester Medical Center, Valhalla, New York.

Klaus F Kofoed (KF)

Department of Cardiology & Radiology, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.

Joshua B Goldberg (JB)

Section of Cardiothoracic Surgery, Westchester Medical Center, Valhalla, New York.

Cenap Undemir (C)

Section of Cardiothoracic Surgery, Westchester Medical Center, Valhalla, New York.

Ryan K Kaple (RK)

Division of Cardiology, Yale University School of Medicine, New Haven, Connecticut.

Pinak B Shah (PB)

Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts.

Tsuyoshi Kaneko (T)

Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Steven L Lansman (SL)

Section of Cardiothoracic Surgery, Westchester Medical Center, Valhalla, New York.

Sahil Khera (S)

Division of Cardiology, Mount Sinai Medical Center, New York, New York.

Jason C Kovacic (JC)

Division of Cardiology, Mount Sinai Medical Center, New York, New York.

George D Dangas (GD)

Division of Cardiology, Mount Sinai Medical Center, New York, New York.

Stamatios Lerakis (S)

Division of Cardiology, Mount Sinai Medical Center, New York, New York.

Samin K Sharma (SK)

Division of Cardiology, Mount Sinai Medical Center, New York, New York.

Annapoorna Kini (A)

Division of Cardiology, Mount Sinai Medical Center, New York, New York.

David H Adams (DH)

Department of Cardiovascular Surgery, Mount Sinai Medical Center, New York, New York.

Omar K Khalique (OK)

Division of Cardiology, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York.

Rebecca T Hahn (RT)

Division of Cardiology, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York.

Lars Søndergaard (L)

The Heart Center, Rigshospitalet, Copenhagen, Denmark.

Isaac George (I)

Division of Cardiac Surgery, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York.

Susheel K Kodali (SK)

Division of Cardiology, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York.

Ole De Backer (O)

The Heart Center, Rigshospitalet, Copenhagen, Denmark.

Martin B Leon (MB)

Division of Cardiology, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York.

Vinayak N Bapat (VN)

Division of Cardiac Surgery, NewYork-Presbyterian Hospital, Columbia University Medical Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH